
Supplier taps gut health benefits of glucosamine
Armed with a new study, TSI Group will be pushing a new indication for its vegan glucosamine ingredient — gut health.

Armed with a new study, TSI Group will be pushing a new indication for its vegan glucosamine ingredient — gut health.

Ingredients by Nature (IBN) has announced a partnership with Canada-based Virentia in preparation for launching ChloroBlast, a new chloroplast concentrate from alfalfa.

From the creators of Quicksilver Scientific, the Apricō line features cutting-edge nanoemulsion technology in several formats.

Economic dislocation from the pandemic continues to send shock waves through the supply of botanical raw materials and will necessitate a new mindset about supply chain integrity in the future, experts say. The issue will be a key focus at an upcoming...

News in brief
Specialty health and wellness retailer The Vitamin Shoppe will offer personal care products from Hims & Hers Health, Inc. in over 280 stores and online across the US.

The Cannabidiol (CBD) market is set to undergo a period of consolidation, buoyed on by a stricter regulatory process in the UK and Europe that will inevitably raise standards and range of applications.

Personalised Nutrition (PN) offers opportunities both for performance and active sports nutrition, according to FMCG Gurus’ Head of Research & Insight, Mike Hughes but affordability remains a sticking issue.

Newly established Australian firm Openway Food, which owns health food brands such as Red Tractor and Raise the Bar, is aiming for further distribution in Asia after gaining traction in China and the US.

Our latest round-up features on new innovations from a2 milk, an infant formula containing novel lipid structure by Danone, to new omega-3 and probiotics launches targeted at infants and young children.

NutraIngredients-Asia Awards 2021
Australian health supplement company Visdon, winner of the botanical product of the year at the NutraIngredients-Asia Awards 2021, is gearing up to launch 20 new products by next year, targeted for specific consumer groups as well as the general population.

China leads the world with the highest number of research publications on traditional, complementary, and integrative medicines (TCIMs) in relation to COVID-19 clinical trials, followed by India, US, and Iran.